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We have previously shown that the retinoblastoma protein (pRb)
can activate expression of Runx2-dependent, bone-specific genes
in cultured cells. We now show that pRb also plays a role early in
osteogenesis, and that in primary RB1/ calvarial cells there is an
increased osteoprogenitor pool. To understand pRb’s function in
vivo, we generated a conditional RB1-KO mouse in which pRb
expression is efficiently extinguished in osteoblasts. These animals
display an apparent developmental defect in bones,most strikingly
in the calvaria. Cultured RB1/ calvarial osteoblasts fail to cease
proliferation upon reaching confluence or following differentia-
tion. Re-plating assays of primary RB1/ calvarial cells after
differentiation showed a clear adipogenic ability with increased
multipotency. RB1/ osteoblasts display a severe reduction in
levels of mRNAs expressed late in differentiation. In this study, we
present strong evidence that pRb has multiple regulatory roles in
osteogenesis. Furthermore, in the absence of RB1/ there is a
larger pool ofmultipotent cells comparedwith theWT counterpart.
This increased pool of osteoprogenitor cells may be susceptible to
additional transforming events leading to osteosarcoma, and is
therefore key to understanding RB1 as a target in malignancy.
differentiation  retinoblastoma protein  osteoprogenitors
The retinoblastoma protein (pRb) is a tumor suppressorwhose regulatory pathway is targeted in most human cancers
(1, 2). pRb and its related pocket proteins, family members p107
and p130, mediate a number of cell processes including cell cycle
progression, differentiation, and apoptosis. pRb functions in
every cell type to control the exit from G1 by regulating the E2F
family of transcription factors. This process of repressing E2F
family members prevents S-phase progression and promotes cell
cycle exit during differentiation and senescence programs (3–7).
Although the pRb pathway is affected in many human cancers,
it is targeted directly in only a subset of tumors. Individuals with
inherited heterozygous loss of the RB1 gene develop retinoblas-
toma and have as much as a 1,000 fold increase in incidence of
osteosarcoma (7–9). More rarely, RB1 is targeted in small-cell
lung carcinoma, bladder carcinomas, and other tumors. This
suggests that tumors exhibiting the highest frequency of pRb loss
may require pRb function in multiple cell cycle exit programs
discrete from specific mediation of S-phase gene expression.
Numerous studies have addressed the role of pRb in cellular
differentiation. These include myogenesis (10, 11,) chondrogen-
esis (12), adipogenesis (4, 13), and osteogenesis (14). To better
understand the role of pRb in tumor formation in a tissue in
which it is commonly deleted, we decided to focus on pRb’s role
in bone development and osteosarcoma formation. Osteosarco-
mas are often highly aggressive neoplasms that rapidly progress
and eventually recur and give rise to distant metastases, primar-
ily to the lung. Osteosarcoma is the most common primary
malignant tumor of bone apart from myeloma (15), and 81% of
osteosarcomas are either poorly differentiated or undifferenti-
ated (16). Osteosarcoma is characterized by the direct formation
of bone or osteoid by the tumor cells (15). This implies that
osteosarcoma is dependent on events related to commitment to
the osteoblast lineage. Not surprisingly, mutation of the RB1
locus occurs in as many as 60% of all osteosarcomas (80% in
pediatric cases) and is considered an essential step in tumor
formation (17).
Several lines of evidence indicate pRb is required for normal
osteogenesis. Osteoblast differentiation can be inhibited in
conditionally immortalized cells by the viral oncoproteins SV40
large T antigen and E1A 12S, which specifically target the pocket
proteins (18). Further, work with the human osteosarcoma cell
line SAOS2 has shown that re-expression of pRb alone is
sufficient to force senescence and drive the expression of mark-
ers reminiscent of osteoblast differentiation (6, 7). The ability of
pRb to promote osteoblast differentiation may be separable
from its role as a regulator of the E2F family of transcription
factors, as re-introduction of a pRbmutant (R661W), lacking the
canonical E2F binding capacity, is capable of arresting and
differentiating SAOS2 cells (6).
Osteogenesis is a multistep process regulated by several
different transcription factors. Runx2 is the ‘‘master regulator’’
of this molecular pathway, required for mineralization of the
skeleton and transcriptional regulation of many genes key to
osteogenesis (19, 20). We have previously shown that hypo-
phosphorylated pRb physically interacts with RUNX2 in vitro
(14). This interaction augments RUNX2-dependent transcrip-
tion from osteoblast-specific promoters. In the absence of pRb,
BMP2-treated mouse embryonic fibroblasts (MEFs) do not
terminally differentiate as measured by mineralization and ex-
pression of bone-specific genes. Interestingly, the early marker of
differentiation, alkaline phosphatase (ALP), showed similar
relative induction between RB1/ and RB1/MEFs. From this
work we concluded that pRb acts as a transcriptional co-activator
of Runx2 functioning in late osteogenic differentiation (14).
In this study, we present strong evidence that, in addition to
pRb’s role late in osteoblast differentiation, it also plays a critical
role early in commitment to the osteoblast lineage. Furthermore,
in the absence of RB1/ there is a larger pool of multipotent
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cells compared with the WT counterpart. This increased pool of
osteoprogenitor cells may be susceptible to additional trans-
forming events leading to osteosarcoma, and therefore key to
understanding RB1 as a target in malignancy.
Results
Bone-Targeted Knockout of the Retinoblastoma Gene. Homozygous
null RB1/mice die at E11.5 to E13.5, before mineralization of
the skeleton is achieved. Therefore, to overcome the early
placental defects that contribute to embryonic lethality in germ-
lineRB1-null mice (21), and to ablateRB1 efficiently in the bone,
we used the Cre/lox site directed recombination system. Mice in
which exon 19 of RB1 is f lanked by loxP sites (22) were crossed
with a transgenic mouse strain that expresses the Cre recombi-
nase under the collagen 1a1 promoter, 3.6Col1a1, which ex-
presses highly in the bone (23). 3.6Col1a1Cre;RBf19/f19 mice are
born at the expectedMendelian ratio but the animals die at birth
as a result of collateral RB1 deletion in vital tissues. Skeletons of
the RB1/ mice were examined by differential staining of
cartilage (Alcian blue) and bone and other mineralized tissues
(alizarin red) [supporting information (SI) Fig. S1 and SI
Materials and Methods]. RB1-KO mice display morphological
and mineralization defects in the xiphoid process of the sternum,
defects in the appearance of ossification centers of the digits of
the fore- and hind-limbs, and a mineralization deficiency in the
apical portion of the cranial vault. To determine if the miner-
alization defect seen in the calvaria represented an absence of
osteoblasts in the apical area, we checked for expression of the
early marker of differentiation, ALP activity. We found staining
along the entire circumference of the calvaria in both WT and
RB1/ animals (Fig. S2 and SI Materials and Methods). How-
ever, when staining for mineral by the Von Kossa method, we
failed to detect it at the apex of the calvaria in RB1/mice (Fig.
S2 and SI Materials and Methods) as anticipated from the results
in Fig. S1. These phenotypes of RB1/ animals are consistently
observed, but it is not clear whether they result from cell
autonomous alteration in osteoblast function, or if there is an
influence of additional RB1/ tissues, as bone is subject to
various autocrine and paracrine signaling events. Therefore, we
elected to isolate and interrogate the effects of pRb loss on
osteoblasts in vitro by isolating cells from the calvaria.
Cultured Primary Osteoblasts from RB1/ Mice Show Altered Prolif-
eration and Mineral Formation Abilities at High Cell Density. There
are two methods of bone formation: endochondral or intramem-
branous ossification. Both forms of bone arise from mesenchy-
mal cells, but the endochondral method, involved in most
skeletal long bones, is complex and involves the formation of a
cartilage template that is later replaced by bone (24). Intramem-
branous bone formation, mainly found in the flat bones of the
skull, is less understood but is arguably simpler in that the cells
of these condensations differentiate directly into bone-forming
osteoblasts (24). The murine calvaria are a rich source of
intramembranous osteoblasts that are readily cultured and an-
alyzed in vitro. To interrogate the mineralization defect of the
RB1-KO animals, calvarial osteoblasts from E18.5 animals were
cultured. These cells were first examined for pRb expression by
immunoblotting, which revealed a complete absence of the
protein (Fig. 1A). We then measured proliferation rates of
RB1/ osteoblasts and litter-mate control WT cells. As antic-
ipated from work in RB1/ MEFs (25), these proliferation
analyses showed that sub-confluent RB1/ osteoblasts prolif-
erate at a rate similar to that observed for their WT counterparts
(Fig. 1B). However, the RB1/ osteoblasts continue to prolif-
erate after reaching high cell densities, whereas the WT osteo-
blasts cease proliferation by day 14. These data are further
supported by BrdU incorporation studies, which demonstrated
persistent S phase in confluent RB1/ cultures, but not in WT
control cells (Fig. S3 and SI Materials and Methods). In contrast,
Ki67 staining of calvaria obtained from embryonic day 18 mice
showed no discernible differences in proliferative fraction (Fig.
S2 and SI Materials and Methods), consistent with a minimal role
for RB loss in altering proliferation in cell populations already
able to undergo rapid proliferation.
Primary osteoblasts supplied with differentiation media in
vitro activate an osteogenic gene transcription program and
form mineralized nodules, which is thought to correspond to
mature osteoblast functions in vivo. To determine the differen-
tiation capacity and timing of mineral formation in RB1/
cultures, mutant and control WT litter-mate cells were seeded at
the same number, grown to confluence, and treated with media
supplemented with ascorbic acid and -glycerophosphate. Using
this standard protocol of osteoblast differentiation, it is generally
observed that WT cells take approximately 21 days to form
mineralized nodules as detected by alizarin red staining (26).
RB1/ osteoblasts consistently showed earlier and more intense
mineralization than those from their WT litter-mates (Fig. 1C).
This increase in mineralization may result in part from the higher
cell density in the RB1/ osteoblast cultures. In differentiation
media, osteoblasts have been shown to thrive on autocrine
signaling for growth and differentiation in cases of high cell
density (27). Therefore, the increased density of RB1/ cell
cultures may generate a more potent differentiation environ-
ment. Alternatively or in addition, theRB1/ calvaria osteoblast
preparations may contain an increased number of osteoprogeni-
tor cells. Therefore, we set out to distinguish between the
proliferative and differentiation defects by measuring and com-
paring osteoprogenitors present in RB1/ and WT litter-mate
primary osteoblast cultures.
Osteoblasts Lacking RB1 Display Enhanced Osteogenic Potential.As is
the case in many developing tissues, osteoblasts arise through
commitment of a multipotent stem cell, in this case a mesen-
Fig. 1. Proliferative properties and increased mineral deposition in cultured
primary calvarial osteoblasts (A). Immunoblot analysis of extracts of cultured
osteoblasts shows the absence of pRb in col3.6;RB1lox/lox mice. (B) Osteoblasts
were isolated from the calvaria of E18.5 animals and differentiated in -MEM
media supplementedwith ascorbic acid and-glycerophosphate. Total cell num-
bersweredeterminedat 1, 7, 14, 21, and28days after platingat an initial density
of500cells/cm2.*,P0.05. (C)Mineraldepositionwasdetectedusingalizarin red
at 0, 7, 14, and 21 days following addition of differentiation medium.
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chymal stem cell, to the osteoblast lineage to produce an
osteoprogenitor cell (OPC). Considerable progress in identify-
ing cell surface markers on analogous stem and progenitor cells
has beenmade in some tissues, such as blood and breast, but such
makers are not well defined in the osteoblast system. Thus, a
functional, in vitro assay is at present the best way to measure
OPC cell numbers and function. One such method to measure
OPCs is by a colony formation assay (28). It has been shown that
the number of nodules that form can be used as an approximate
index of the number of OPCs present in the original cell
population. The idea is that a single initiating cell, referred to as
a colony forming unit (CFU-O), gives rise to all of the cells
necessary for nodule formation (28). To measure CFU-Os
present in RB1/ cultures, osteoblasts were plated at a low
density to allow individual cells to form individual colonies.
These plates were then stained for ALP activity, an early marker
of the osteoblast lineage. The ratio of ALP-positive colonies
(i.e., CFU-Os) to the total number of colonies formed (i.e.,
CFU-Fs) is determined by subsequent crystal violet staining,
allowing a determination of the fraction of colonies with osteo-
genic potential. Colonies of sufficient size for analysis formed 10
days after plating. The ratio of CFU-O to CFU-F was approx-
imately twofold greater in the cultures fromRB1/mice relative
to those fromWT (Fig. 2A). This increase in the ratio of CFU-O
to CFU-F is not accompanied by an overall increase in the total
number of colonies (Fig. 2B), which is consistent with the similar
proliferation rates of sub-confluent RB1/ and WT osteoblasts
(Fig. 1B). There was an earlier appearance of ALP-positive
colonies in the RB1/ cultures, which suggests an acceleration
of osteoblast differentiation or that an increased fraction of
osteoblasts in RB1/ calvaria had advanced to the point of ALP
expression at the time of cell harvest.
The CFU-O assay described is consistent with an increase in
OPCs in RB1/ osteoblast cultures. To obtain independent
evidence of this and to extend our analysis of progenitor numbers
and function in these cultures, we next performed a sphere
formation assay. Sphere formation assays have long been used to
show progenitor/multipotent cell populations in the human and
murine mammary epithelial system (29–31). Several studies
suggest that bone marrow derived cells can also produce spheres
(32, 33), but to our knowledge there is no work that shows cells
from murine calvaria can or should be able to form spheres. To
determine if calvarial osteoblast preparations contained sphere-
forming ability, cells were seeded on ultra-low adherent tissue
culture plates in AlphaMEM medium supplemented with 10%
FBS. Three to four days later, sphere formation was evident
either in the presence or absence of RB1 (Fig. 2D). Interestingly,
there is a noticeable difference in sphere number in RB1/
primary calvarial preparations compared with those from WT
litter-mates (Fig. 2C). These spheres were isolated, disassoci-
ated, and re-plated on non-adherent plates. Twice as many
secondary spheres were generated from RB1/ primary cul-
tures compared with those from WT litter-mates. The overall
reduced number of secondary spheres may result from subop-
timal culture conditions, as we have yet to determine the nature
of these ‘‘osteospheres,’’ and/or these osteoprogenitors may have
a limited passage capability. For example, additional growth
supplements must be added to the media to maintain optimal
levels of mammosphere formation (34). These data strongly
suggest that primary calvarial cells in the absence of RB1 have
an increased osteoprogenitor cell population that may also
consist of a population of cells that are able to self-renew and
form spheres, and may be multipotent in nature. To further
assess whether the cells are multipotent, we next determined if
the cells could be differentiated into other cell types.
RB1/ Osteoblasts Can Differentiate into Osteoblast and Adipose
Cells. Mesenchymal stem cells are able to differentiate into
several cell types including adipocytes, chondrocytes, and osteo-
blasts. Some evidence suggests that mesenchymal stem cells from
bone marrow can also give rise to myoblasts and fibroblasts, and
possibly to non-mesenchymal lineages (35) (Fig. 3A). To deter-
mine if RB1/ calvarial osteoblast preparations contain multi-
potent cells, we treated the primary cells with standard differ-
entiation protocols for osteoblasts, adipocytes, or myoblasts. As
shown earlier, RB1/ cells treated with osteoblast differentia-
tion medium display increased mineral formation as determined
by alizarin red S stain (Fig. 3B). To extend characterization of
this osteoblastic differentiation, we analyzed the expression of
several mRNAs encoding osteoblast-specific genes. We found
that expression of Runx2 mRNA as well as that of osteopontin,
a gene expressed at medium to late times after initiation of
osteoblast differentiation, is unaffected in the presence or
absence ofRB1 (Fig. 3C). In contrast, osteoblast/osteocyte factor
45 (OF45), a late marker tightly linked to mineralization (36),
was found to be poorly expressed in RB1/ osteoblasts in
comparison to WT osteoblasts. Similarly, osteocalcin, another
late marker of osteoblast differentiation, is detectable in differ-
entiated RB1/ osteoblasts, but at levels vastly reduced com-
pared with those inWT cells (Fig. 3C). Thus, expression of genes
acting late in osteoblast differentiation is severely impaired in
RB1/ osteoblasts, just as was previously observed in BMP2-
treated RB1/MEFs (14). However, increased CFU-O number
and persistent expression of genes expressed at early to middle
times after initiation of differentiation supports the notion that
functional osteoprogenitors may be present at increased num-
bers in RB1/ calvarial preparations.
Next we asked if the progenitor cells present in RB1/
calvarial cell cultures were able to differentiate into cells other
than osteoblasts. We focused on the adipocyte lineage, as this
cell type is thought to arise from a common progenitor proximal
Fig. 2. Quantitation of osteoprogenitors in primary calvarial osteoblast
cultures. (A) Colony assay todetermineosteoprogenitor cell numbers. Primary
osteoblasts were seeded at low density and cultured for 24 days. Colonies of
CFU-O from single cells were stained for ALP activity, and the CFU-F was
determined by crystal violet staining. A colony was counted if it was a
minimum of 10–20 mm in diameter. A minimum of 10 cells per colony had to
be ALP-positive to be counted as one CFU-O. The ratio of CFU-O to CFU-F was
increased in the cultures from RB/ mice (dashed line) relative to those of
their control litter-mates (solid line). *, P 0.05. (B) Total number of colonies
formed by osteoblasts derived from RB1/ and WT animals. (C) Sphere
formation assay for progenitor/multipotent cells in the calvarial cell popula-
tion. Primary osteoblasts were seeded at 1.5  104 cells/cm2 on ultra-low
adherent plates. Spheres were counted after 3 and 6 days. Primary spheres
were collected, counted, trypsinized, and re-plated onto ultra-low adherent
plates. Secondary sphereswere counted after 6 days **, P 0.05. (D) Image of
primary spheres from RB/ and RB-WT calvaria cells.
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to osteoblast commitment, as is depicted in Fig. 3A. To stimulate
adipogenesis, cells fromWT or RB1/ calvaria were cultured in
adipogenic medium (insulin, isobutylmethylxanthine, and dexa-
methasone). No adipogenesis was observed in WT osteoblast
cultures, indicating that progenitor cells in these cultures may be
committed to the osteoblast lineage. A similar resistance to
adipogenic media has been reported in MEFs (4). In contrast,
RB1/ calvarial osteoblast cultures demonstrated robust differ-
entiation to adipocytes as revealed by oil red O staining (Fig.
3D). These results clearly show that primary calvaria cells in the
absence of RB1 are able to differentiate into cell lineages other
than osteoblasts, supporting the persistence or accumulation of
multipotent progenitor cells in the skulls of mutant animals.
pRb Is Needed for Terminal Cell Cycle Exit. The data described
suggest that loss of RB1/ in calvarial osteoblasts impairs late
gene expression and increases the number and potential of
progenitor cells. To determine how RB1 loss might alter the
proliferative capacity of differentiating progenitor cells, we next
asked if pRb is involved in mediating permanent cell cycle arrest,
a feature often associated with ‘‘terminal’’ differentiation. To
this end, we trypsinized osteoblast cultures that had been in a
confluent, differentiating condition for 28 days, re-plated these
cells at the starting sub-confluent dilution, and performed a
proliferation assay. Cell cycle analysis indicated that neither
RB1/ norWT cultures contained proliferating cells at this time
(data not shown).WT osteoblasts numbers failed to expand after
re-plating. However, RB1/ osteoblasts proliferated and repop-
ulated the dish (Fig. 4). Further, when we assayed for mineral
formation after addition of ascorbic acid and -glycerophos-
phate as a measure of differentiation, RB1/ cells stained
robustly but WT cells failed to differentiate. In addition, to
determine if cells maintained multi-potency, the re-plated cells
were treated with adipogenic medium for 14 days. Similar to the
initial primary cell preparations, RB1/ cells demonstrated
substantial differentiation to adipocytes, as revealed by oil red O
staining (Fig. 4C). Therefore, pRb appears to be necessary for
permanent cell cycle arrest of osteoblasts subjected to differen-
tiation-inducing agents in culture.
Discussion
We have previously reported that direct interaction between
pRb and Runx2 is required for osteocalcin expression late in
osteoblast differentiation stimulated by BMP2 treatment of
MEFs (14). We now show that pRb may also play a role early in
osteogenesis, and that in primary RB1/ calvarial cells there is
an increased osteoprogenitor pool. Loss of RB1 in the osteo-
progenitors results in mineralization defects in both endochon-
dral and intramembranous bones. In vitro, RB1/ cells treated
with differentiation medium mineralize significantly earlier than
their WT counterparts, in seeming contradiction to the in vivo
observation of reducedmineralization. However, in keeping with
our previously published work (14), we found that induction of
the expression of terminal markers of osteoblast differentiation,
osteocalcin, and OF45 was severely impaired in RB1/ cells
(Fig. 3C). It is interesting to note that the osteocalcin-KO mouse
model showed an osteopetrotic phenotype, suggesting osteocal-
cin is a negative regulator of bone mineralization (37). Further,
OF45 has also been shown to limit bone formation in vivo (38).
Therefore, the absence of the expression of these genes may in
part explain the increased mineral formation seen in RB1/
calvarial osteoblasts in vitro.
Fig. 3. Primary calvaria cells from RB1/ mice can be differentiated into osteoblasts and adipose cells. (A) Schematic drawing of mesenchymal cell
differentiation. (B) Primary RB/ and RB/osteoblasts from the calvarial were grown to confluence and differentiated for 28 days with osteoblast
differentiation media. Cells were stained with alizarin red. (C) RT-PCR for Runx2, osteopontin, OF45, and osteocalcin. mRNAwas prepared from cells treated as
in B. (D) Primary RB/ and RB/ osteoblasts from calvaria were grown to confluence and differentiated for 19 days with adipose differentiation media. The
cells were then stained with oil red O. The images are a representative of three cell preparations for each genotype.
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Both increased number of CFU-O and increased mineraliza-
tion are consistent with persistence of calvarial osteoblasts in a
proliferative, progenitor-like state. Continuous, strong differen-
tiation signals in vitro appear to stimulate mineral deposition,
and we predict that similar effects may be observed in vivo in
older animals lacking RB1/ in bone. However, the early death
of the animals used in our analyses prevents us from asking if
excessively proliferative osteoblasts persist in RB1/ animals
throughout life or if these cells eventually succeed in mineral-
izing the affected areas. Future experiments using partially
penetrant cre alleles expressed specifically in the bone may help
to identify an excess of proliferative osteoprogenitors and al-
tered mineralization in older animals. In addition to generating
a higher number of cells with characteristics of osteoprogenitors
(i.e., ALP-positive CFU-O number and sphere forming activity
in addition to increased mineralization), RB1/ calvarial cells
showed additional progenitor-like changes in comparison toWT
cells. First, whereas WT cells subjected to 3 to 4 weeks of
differentiation lost all proliferative capacity upon re-plating,
RB1/ cells were readily able to expand and produce a high
number of mineralization competent cells, suggesting that at
least some RB1/ calvarial cells resisted the cell cycle exit
displayed by differentiated WT cells. Second, RB1/ calvarial
cells showed a clear adipogenic ability (although no change in
myogenic ability) consistent with increased multi-potency.
WhetherRB1/ osteoblasts ‘‘back up’’ to display properties of
multipotent progenitors or if loss of RB1 delays progression of
a pool of multipotent progenitors normally found in calvarial
condensates requires further study. Similarly, the ability of
re-plated, differentiated RB1/ osteoblasts to proliferate and
mineralize may represent a ‘‘de-differentiation’’ of cells that had
responded to differentiation media or alternatively may result
from persistence of progenitor-like cells in these cultures. In-
deed, our preliminary studies suggest that sphere formation and
adipogenic abilities are present in re-plated cells following
differentiation of RB1/ cells. Finally, we note that, although
several different primary cell preparations for each genotype
were examined for each differentiation assay with equivalent
results, there is the possibility that these cultures contain a mixed
population of progenitors individually able to generate osteo-
blasts or adipocytes. The possibility of obtaining multiple
RB1/ cell types from these animals is supported by our
observation that RB1 is lost in all tissues of animals expressing
3.6-Col1a1-Cre, and this expression begins at approximately
embryonic day 10. To begin to examine this issue, we have
established immortalized cell lines that are clonally derived from
the primary cultures and have initially found that RB1/, but
not WT cell lines, also possesses both adipogenic and osteogenic
properties, consistent with the immortalization of a single mul-
tipotent progenitor cell (data not shown).
How pRb acts to attenuate early osteoblast progression and/or
proliferation is not known. However, it is noteworthy that the
multiple functions of pRb as an inhibitor of progenitor prolif-
eration, mediator of progression, and effector of late differen-
tiation and cell cycle exit would limit the size of the osteopro-
genitor pool. Loss of pRb would then be expected to increase the
progenitor pool while reducing terminal differentiation and cell
cycle exit. Overall, the data presented here suggest that pRb
function acts to regulate several aspects of osteoprogenitor and
osteoblast proliferation and differentiation in vivo. We propose
that pRb is a major coordinator of proliferation and differen-
tiation events throughout bone development. Furthermore, in
the absence of RB1, there is a larger pool of multipotent cells
compared with the WT counterpart. This increased pool of
osteoprogenitor cells may be susceptible to additional trans-
forming events leading to osteosarcoma, and indeed loss of RB1
in the mouse has recently been shown to cooperate with p53 loss
to generate bone tumors (39, 40). Studies of pRb-null progen-
itors such as those performed here are thus key to understanding
RB1 as a target in malignancy.
Materials and Methods
Animals. The flox19-RB1 mice were obtained from the laboratory of Doug
Hanahan (San Francisco, CA) and maintained in a C57BL/6 background. 2.3-
and 3.6-Col1a1-Cre transgenic mice were obtained from the laboratory of
Barbara Kream (Farmington, CT). The F1 RBf19/WT;Col1a1-Cre mice were
self-crossed and the resulting F2 mice were used in our studies.
Calvarial Cell Preparation and Culture. Calvariae (topmost skull bones) from
18.5-day embryos were removed, subjected to a series of collagenase diges-
tions at 37 °C, pooled, and then plated on one 10-cm dish per embryo in
-MEM medium (Invitrogen). Cells were maintained in -MEM plus 10% FBS
and 1% penicillin-streptomycin (Gibco; basic media). Primary cells were dif-
ferentiated using 0.01M -glycerophosphate, 100mM l-ascorbic acid, and 0.1
Mdexamethasone (Sigma) inbasicmedia forosteoblastdifferentiation.Cells
were stained with 2% alizarin red. For adipose differentiation, 0.1 M dexa-
methasone, 0.5 mM isobutylmethylxanthine, and 5 g/ml h-insulin (Sigma)
were added tobasicmedia. Cellswere stainedwithoil redOas described later.
Immunoblotting. Immunoblot analysis was performed as described previously
(7). The following antibodies were used: human monoclonal antiRB: 245
(PharMingen) and anti-GAPDH (Chemicon). Horseradish peroxidase-
conjugated secondary antibody was used (Jackson ImmunoResearch) and
signal was detected by ECL (NEN).
Oil Red O Staining.Oil red Owas prepared as described (41). The final staining
solutionwas 0.2%oil redO in 60% isopropanol (working solution). Cells were
washed twice with PBS solution and fixed with 10% buffered formalin phos-
phate (Fisher) for at least 1 h at room temperature. The cells were washed
twicewithwater, then stained for 2hwithoil redOworking solution. The cells
were washed with water, and the excess water was evaporated at room
temperature. The stained cells were imaged under a microscope.
Quantitative Real-Time PCR.RNAwas extracted fromprimary osteoblasts using
TRIzol (Invitrogen) according to themanufacturer’s protocol. Ten nanograms
of total RNA was used for first-strand cDNA synthesis using the iScript cDNA
synthesis kit (Bio-Rad) according to the manufacturer’s instructions. Quanti-
Fig. 4. Re-plated RB1/ osteoblasts retain the ability to proliferate and
differentiate into osteoblasts and adipose cells. Osteoblasts were allowed to
differentiate as described in Fig. 2. After 28 days in differentiationmedia, cells
were trypsinized, re-seeded, and differentiated anew. (A) RB1/ osteoblasts
proliferated in culture and were capable of differentiating as measured by
mineral formation visualizedwith alizarin red (B). These resultswereobserved
twice. (A) WT cells failed to grow after re-plating, and showed no response to
differentiating agents (B). (C) The trypsinized cells were re-plated and differ-
entiated with adipogenic medium for 14 days. RB1/ cells were capable of
forming adipocytes, as determined by oil red O staining, whereas RB1/ cells
showed no adipocyte-like cells.
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tative PCR was carried out by employing the QuantiTect SYBR green PCR kit
(Qiagen) and using 1 l of the cDNA reaction. Primer sequences and PCR
conditions are available on request. Relative quantification of gene expres-
sion was carried out by the comparative CT method (42).
Colony Formation Assay. Colony formation assay was performed as described
previously (43). Primary calvarial osteoblasts were re-seeded the day after
isolation at a concentration of 500 cells/cm2. After 10 days in differentiation
media, cells were fixed and stained for ALP activity with 10 mg naphthanol
AS-MX (Sigma), 20 mg Fast Blue BB salt (Sigma), 1 ml N,N-dimethylformaide
(Sigma), in 19 ml of 0.1 M Tris (pH 9.2) to detect CFU-O. Colonies greater than
1mm in diameter were countedwith a dissectingmicroscope. CFU-fibroblasts
were detected by then staining the same plates with 0.2% crystal violet in 2%
ethanol for 1 h. Plates were washed with water and then air-dried.
Sphere Formation Assay. Primary cells from mouse calvaria were seeded at 1 
105 cells/6 cm2 on an ultra-low attachment dish (Corning) in AlphaMEM (Invitro-
gen) plus 10% FBS and 1% penicillin-streptomycin (Gibco). Primary cells were
counted after 3 days in culture, trypsinized, strained through a 40-mBD Falcon
strainer, and re-plated. Secondary spheres were counted on day 6.
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SI Materials and Methods
Whole-Mount Skeletal Analysis. Skeletons of 18.5-d fetuses and
adults were fixed in 95% ethanol for 24 h. Detection of miner-
alization by alizarin red S and Alcian blue (Sigma) were per-
formed as previously described (1).
Histology and Immunohistochemistry. For histological analysis,
E18.5 and neonatal mice were killed and whole animals were
fixed in 10% formalin/PBS solution and paraffin-embedded, and
coronal sections were made of the calvaria to assess ALP and von
Kossa staining. ALP staining was carried out by deparaffinizing
the coronal sections, washing in AP buffer (100 mM Tris-HCl,
100 mM NaCl, 5 mM MgCl2, 0,05% Tween, pH 9.5), staining
with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazo-
lium (Sigma) to detect ALP activity, and counterstaining with
fast red. Von Kossa staining of coronal sections to detect
mineralization was achieved by deparaffinization, immersion in
5% silver nitrate solution, and exposure to UV light for 15 min,
followed by counterstaining with fast red. For detection of Ki67,
primary rat antimouse antibody (DakoCytomation) was incu-
bated for 30 min. After incubation with an HRP-conjugated
secondary antibody, staining was visualized with DAB peroxi-
dase substrate.
BrdU Indirect Immunofluorescence. Primary cell preparations
(5,000 cells/chamber) were seeded in eight-chambered tissue
culture slides and cultured for 1 h in the presence of 10 MBrdU
before being collected and processed for anti-BrdU immuno-
fluorescence. Briefly, cells were fixed for 20 min in 4% para-
formaldehyde in PBS solution and permeabilized for 30 min in
2% BSA/0.2% Triton X-100 in PBS solution. Chamber slides
were treated at room temperature with biotinylated anti-BrdU
antibody (BD PharMingen) diluted 1:200 in 2% BSA/0.2%
Triton X-100 in PBS solution for 1 h. Slides were washed and
incubated for 30 min at room temperature with Alexa Fluor
546-conjugated goat anti-mouse (Invitrogen) diluted 1:100 in
PBS solution. DNA was stained with Hoechest 33258 nuclear
stain for 5 min. Cells were rinsed three times with high-salt PBS
solution and 1 time with PBS solution and mounted with
Fluoromount-G mounting medium (Southern Biotech).
1. Komori T, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell 89:755–764.
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Fig. S1. In vivomineralization defect inCol3.6-Cre; Rbf19/f19mice. Whole skeletons were stained with alizarin red (mineralized tissue) and Alcian blue (cartilage).
Conditional RB1-KO mice (RB/) at E18.5 show significant defects in the mineralization of the cranial vault and in the appearance of ossification centers of the
distal metacarpals, distal and proximal phalanges, and in the xiphoid process of the distal sternum compared with WT (RB/) litter-mates.
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Fig. S2. In vivo mineralization defect in Col3.6-Cre; Rbf19/f19 mice. Coronal sections of RB1-WT and null mice. ALP activity (Top), mineral deposition (von Kossa,
third row), and proliferating cells (Ki67, Bottom) were visualized in cranial sections of WT or RB-KO mice. Alkaline phosphatase activity (blue) appears equivalent
in both genotypes; however, mineralization as detected by the Von Kossa method (black) is absent at the apical-most area of the calvarium in RB1/ animals.
Ki67 staining (brown,Bottom) inRB-null animals shows a similar level of proliferation compared with that inRB1/ animals. These sections were counterstained
with hematoxylin (blue).
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Fig. S3. In vitro incorporation of BrdU in post-confluent RB1/ primary cell preparations. (Top) Sub-confluent primary calvarial preparations (70% confluence)
were treated for 1 h with BrdU and then processed for indirect immunofluorescence as described in Materials and Methods. Both RB1/ and RB1/ cell
preparations incorporated BrdU at similar rates. The percentage of BrdU-positive cells was 3.7  1.1 for both genotypes, determined in three different visual
fields. BrdU-positive cells are indicated by an arrowhead. (Bottom) Calvarial cell preparations were treated at 3 days after confluence for 1 h with BrdU and
processed for indirect immunofluorescence as described. RB1/ cell preparations continue to incorporate BrdU, whereas RB1/ cells do not. Total nuclei were
visualized by DAPI staining. Images shown are representative of three independent cell preparations for each genotype.
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